Connor, Clark & Lunn Investment Management (CC&L)
TRIL

Connor, Clark & Lunn Investment Management (CC&L)’s Trillium Therapeutics Inc. TRIL Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TRIL Stock Details TRIL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$355K Sell
2021
Q2 		$3.32M Sell
2021
Q1 		$3.96M Buy
2020
Q4 		$2.95M Buy